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Three new iridoid glycosides, named involucratosides A – C (1 – 3), were isolated from the H2O subextract of
crude MeOH extract prepared from the aerial parts of Asperula involucrata along with a known iridoid glycoside
(adoxoside), three ﬂavone glycosides (apigenin 7-O-b-glucopyranoside, luteolin 7-O-b-glucopyranoside, apigenin 7-O-
rutinoside) as well as two phenolic acid derivatives (chlorogenic acid and ferulic acid 4-O-b-glucopyranoside). Their
chemical structures were established by UV, IR, 1D- (1H, 13C and JMOD) and 2D- (COSY, HSQC, HMBC and NOESY)
NMR experiments and HR-ESI-MS. In addition, the crude extract, subextracts and isolates were evaluated for their
xanthine oxidase inhibitory and antioxidant activities in in vitro tests. This is the ﬁrst report on the chemical
composition and bioactivities of A. involucrata.
Keywords: Asperula involucrata, Rubiaceae, Iridoid glycosides, Involucratosides A – C, Xanthine oxidase inhibitory
activities, Antioxidant activities.
Introduction
The genus Asperula L. belongs to Rubiaceae family
and contains around 200 species distributed world-
wide. It is represented by 41 species in the ﬂora of
Turkey with an endemism rate of 49%.[1] Asperula
involucrata WAHLENB. is a perennial herb mainly dis-
tributed in the northern parts of Turkey.[2] Some Aspe-
rula species are utilized as diuretic, tonic, antidiarrheal
agents as well as to reduce blood pressure and
inﬂammation in several traditional medicines.[3][4] Pre-
vious phytochemical studies on the genus Asperula
revealed the presence of iridoids, ﬂavonoids, anthra-
quinones and phenolic acids.[5 – 7] In our previous
study, we reported the isolation of new ﬂavonoid and
iridoid glycosides from A. lilaciﬂora.[8] In the continua-
tion of our researches on the isolation of new bioactive
compounds from Asperula species growing in Turkey,
we have investigated the secondary metabolites of
A. involucrata which has not been previously investi-
gated in terms of its phytochemical proﬁle and biologi-
cal activities. Herein we report the isolation and
structure elucidation of nine compounds including
three new iridoid glycosides (1 – 3). Further, xanthine
oxidase inhibitory and DPPH free radical scavenging
activities of the crude extract, subextracts and isolates
were evaluated in in vitro tests as some ﬂavonoids and
iridoid glucosides were previously reported to be the
potential inhibitors of xanthine oxidase enzyme.[9][10]
Results and Discussion
Structure Elucidation
The aerial parts of A. involucrata were extracted with
MeOH. The crude MeOH extract was dispersed in H2O
and submitted to liquid-liquid extraction with CHCl3
to yield H2O and CHCl3 subextracts. The H2O sub-
extract was subjected to various column chromato-
graphy protocols to afford three new compounds
(1 – 3) along with six known ones (4 – 9) (Fig. 1).
Compound 1 was obtained as colorless amorphous
powder. The molecular formula, C27H34O13, was
assigned by HR-ESI-MS (m/z 589.1905 ([M + Na]+), calc.
C27H34NaO13 589.1897) and from the
13C-NMR data.
The UV spectrum of 1 contained a maximum at
221 nm typical for C(4) substituted iridoids and its IR
spectrum displayed absorption bands due to hydroxy
groups at 3402, ester carbonyl group at 1701,
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conjugated C=C at 1632, and an aromatic ring at 1512
and 1440 cm1. The 1H-NMR spectrum (Table 1) of 1
contained an oleﬁnic signal at d(H) 7.44 (s), along with
one hemiacetal signal at d(H) 5.02 (d, J = 7.3 Hz), one
oxymethylene at d(H) 3.52 (dd, J = 10.7, 6.1 Hz) and
3.48 (dd, J = 10.7, 6.6 Hz), three methine signals at
d(H) 2.74 – 2.78 (m), 2.10 – 2.15 (m) and 1.90 – 1.94
(m), two non-equivalent methylene signals at d(H)
2.06 – 2.10 (m), 1.24 – 1.30 (m) and d(H) 1.75 – 1.81
(m), 1.32 – 1.39 (m) which were observed in the same
spin system in COSY spectrum (Fig. 2). Moreover, the
1H-NMR spectrum also displayed an anomeric signal
at d(H) 4.69 (d, J = 7.9) arising from a b-glucopyranose
and a carboxymethyl singlet at d(H) 3.66 (s). These
ﬁndings, taken together with the corresponding
13C-NMR data (Table 2) revealed that 1 is an adox-
oside type iridoid glycoside.[11] However, 1H-NMR
spectrum of 1 exhibited additional signals; a pair of
trans-coupled oleﬁnic signals at d(H) 7.57 and 6.32
(each d, J = 15.8) as well as three aromatic signals at
d(H) 7.05 (d, J = 1.9 Hz), 7.03 (dd, J = 8.4, 1.9 Hz) and
6.93 (d, J = 8.4 Hz) as an ABX system indicating the
presence of a (E)-caffeoyl derivative in 1. 13C-NMR
spectrum of 1 contained 27 resonances, eleven of
which were assigned to iridoid aglycone while six
were attributed to b-glucopyranose, the remaining ten
signals (d(C) 168.8, 151.6, 148.0, 146.8, 128.8, 122.8,
115.8, 114.7, 112.5, 56.4) were characteristic for a
trans-isoferuloyl moiety.[12] The chemical shift values
of CH2(60) signals (d(H) 4.47 and 4.42) of b-glucopyra-
nose unit were shifted downﬁeld around 0.5 and
0.7 ppm in the 1H-NMR spectrum of 1 indicating the
esteriﬁcation site of (E)-isoferuloyl unit to be C(60)–OH
of b-glucopyranose. HMBC spectrum (Fig. 2) conﬁrmed
this assumption by the long-range coupling of car-
bonyl carbon (d(C) 168.8) of (E)-isoferuloyl unit with
the CH2(60) of b-glucopyranose unit. Further key cross-
peaks were evident between C(400) (d(C) 151.6) and
methoxy signal at d(H) 3.89 and between C(11) (d(C)
169.5) and methoxy signal at d(H) 3.66 establishing
the locations of methoxy groups. The relative conﬁgu-
ration of the molecule was elucidated as depicted by
the NOE interactions of H–C(1) (d(H) 5.02)/H–C(8) (d(H)
2.13) and H–C(5) (d(H) 2.76)/H–C(9) (d(H) 1.92) in the
NOESY spectrum. Furthermore, the 13C-NMR data of
the cyclopentan ring were compared to those of C(8)
epimeric iridoids, 8-a-dihydrogeniposide and 8-b-dihy-
drogeniposide (adoxoside).[11] The 13C data of the
aforementioned signals particularly C(7) (d(C) 28.3), C
(8) (d(C) 44.2) and C(10) (d(C) 66.3) were found to be
superimposable with those of adoxoside and showed
signiﬁcant differences from those of 8-a-dihydrogen-
iposide. These data suggested that 1 is the 60-O-(E)-
isoferuloyl ester of adoxoside and named as involu-
cratoside A.
Compound 2 was obtained as colorless amor-
phous powder. The molecular formula was deter-
mined to be C26H32O11 by its HR-ESI-MS (m/z
543.1857 ([M + Na]+), calc. C26H32NaO11, 543.1842)
and 13C-NMR data. The UV and IR spectra were typi-
cal for an ester iridoid. Its 1H- and 13C-NMR spectra
(Tables 1 and 2) of 2 showed characteristic signals
for adoxoside skeleton and were in good agreement
with those of 1. The only difference was due to the
Figure 1. Structures of compounds (1 – 9) from Asperula involucrata.
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aromatic acyl group signals. The 1H-NMR spectrum
of 2 exhibited characteristic signals for a (E)-cinna-
moyl unit at d(H) 7.64 and 6.46 (each d, J = 15.9) as
an AX type and ﬁve aromatic signals at d(H) 7.60 –
7.62 (m, 2 H) and 7.41 (3 H). These ﬁndings
revealed that 2 contains (E)-cinnamoyl unit in its
structure instead of (E)-isoferuloyl unit. The linkage
of the (E)-cinnamoyl group was determined to be C
(20)–OH of b-glucopyranose on the basis of the
downﬁeld shift for H–C(20) (d(H) 4.82) of b-glucopyr-
anose as well as the HMBC correlation between car-
bonyl carbon (d(C) 167.4) of (E)-cinnamoyl unit with
Table 1. 1H-NMR (CD3OD, 500 MHz) data of compounds 1 – 3. d in ppm, J in Hz.
Position 1a 2a 3a
Aglycone
1 5.02 (d, J = 7.3) 5.41 (d, J = 2.5) 5.31 (d, J = 4.4)
3 7.44 (s) 7.30 (s) 7.37 (s)
5 2.74 – 2.78 (m) 2.79 – 2.83 (m) 2.79 – 2.83 (m)
6 2.06 – 2.10 (m) 1.88 – 1.93 (m) 1.99 – 2.02 (m)
1.24 – 1.30 (m) 1.58 – 1.63 (m) 1.52 – 1.59 (m)
7 1.75 – 1.81 (m) 1.65 – 1.69 (m) 1.70 – 1.77 (m)
1.32 – 1.39 (m) 1.33 – 1.38 (m) 1.34 – 1.41 (m)
8 2.10 – 2.15 (m) 1.96 – 2.01 (m)b 2.01 – 2.06 (m)b
9 1.90 – 1.94 (m) 1.96 – 2.01 (m)b 1.93 – 1.97 (m)
10 3.52 (dd, J = 10.7, 6.1) 3.53b 3.52 (dd, J = 10.7, 5.0)
3.48 (dd, J = 10.7, 6.6) 3.50b 3.49 (dd, J = 10.7, 6.3)
COOMe 3.66 (s) 3.58 (s) 3.58 (s)
Glc
10 4.69 (d, J = 7.9) 4.88 (d, J = 8.0) 4.81 (d, J = 8.0)
20 3.24 (t, J = 8.6) 4.82b 4.78b
30 3.41 (t, J = 8.9) 3.63 (t, J = 8.9) 3.55b
40 3.35 (t, J = 8.9) 3.39b 3.36 (t, J = 9.3)
50 3.54 – 3.58 (m) 3.39b 3.31 – 3.34 (m)
60 4.47 (dd, J = 11.8, 2.5) 3.92 (br. d, J = 11.7) 3.89 (dd, J = 11.4, 1.9)
4.42 (dd, J = 11.8, 6.5) 3.70 (dd, J = 11.7, 4.0) 3.68 (dd, J = 11.4, 5.2)
Acyl
20 0 7.05 (d, J = 1.9) 7.60 – 7.62 (m) 7.60 – 7.63 (m)
30 0 – 7.41b 7.32b
40 0 – 7.41b 7.32b
50 0 6.93 (d, J = 8.4) 7.41b 7.32b
60 0 7.03 (dd, J = 8.4, 1.9) 7.60 – 7.62 (m) 7.60 – 7.63 (m)
a 6.32 (d, J = 15.8) 6.46 (d, J = 15.9) 5.88 (d, J = 12.7)
b 7.57 (d, J = 15.8) 7.64 (d, J = 15.9) 6.98 (d, J = 12.7)
40 0-MeO 3.89 (s) –
a Assignments are based on COSY, HSQC and HMBC experiments. b Overlapped signals.
Figure 2. 1H,1H-COSY (bold lines) and key HMBCs (C?H, arrows) for compounds 1 and 2.
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the H–C(20) of b-glucopyranose group. The NOE cor-
relations for the iridoid aglycone were consistent
with those of 1. Thus, the structure of 2 was
deduced as 20-O-(E)-cinnamoyl ester of adoxoside
and named as involucratoside B.
Compound 3 was obtained as colorless amor-
phous powder. It had the same molecular formula
C26H32O11 as 2, determined by its HR-ESI-MS (m/z
543.1848 ([M + Na]+), calc. C26H32NaO11, 543.1842)
and 13C-NMR data. Its NMR data were very similar
to those of 2, except for the chemical shift values
for oleﬁnic protons (d(H) 6.98 and 5.88) of the cin-
namoyl unit which were shifted upﬁeld. This ﬁnding
along with the relatively small coupling constant (J)
values (each 12.7 Hz) of these oleﬁnic signals
implied that the double bond geometry of cin-
namoyl unit was (Z). The other NMR ﬁndings includ-
ing HMBC and NOESY spectra for 3 were identical
with those of 2. Accordingly, 3 was established as
20-O-(Z)-cinnamoyl ester of adoxoside and named as
involucratoside C.
The known compounds were characterized as
adoxoside (4),[11] apigenin 7-O-b-glucopyranoside
(5), luteolin 7-O-b-glucopyranoside (6), apigenin
7-O-rutinoside (7),[13] chlorogenic acid (8),[14] and
ferulic acid 4-O-b-glucopyranoside (9),[15] by com-
parison of their NMR data with those of published
values.
The new iridoid glycosides obtained in this study
are the esteriﬁed derivatives of adoxoside. Iridoid gly-
cosides are regarded as signiﬁcant chemotaxonomic
markers particularly in dicotyledonous families and uti-
lized for the chemotaxonomic evaluation of several
genera and species.[16] Adoxoside-type iridoid glyco-
sides were previously reported from the genera Vibur-
num (Adoxaceae),[17] Castilleja and Euphrasia
(Orobanchaceae).[11] They are also being reported for
the ﬁrst time in the genus Asperula. The occurrence of
such iridoid glycosides in Asperula may contribute to
the chemotaxonomy of the genus Asperula which is
considered to be polyphyletic[18] and may imply a
relationship between Asperula and the genera Vibur-
num, Castilleja and Euphrasia.
Biological Studies
The crude extract, subextracts and isolates were evalu-
ated for their xanthine oxidase inhibitory activities
(Table 3). Only H2O subextract displayed weak xan-
thine oxidase inhibitory with IC50 of 137.3 lg/ml,
while none of the compounds isolated thereof were
found to be active. Although some ﬂavonoids were
previously reported as xanthine oxidase inhibitory
agents from several medicinal plants, the ﬂavonoids
obtained in this study didn’t exert notable inhibitory
activity against xanthine oxidase. The absence of the
activity of the tested ﬂavonoids might be due to their
glycosidic structures, as the ﬂavonoid aglycones such
as apigenin, luteolin, chrysoeriol, diosmetin, hispidulin,
eupatilin, kaempferol and quercetin were found to
inhibit the xanthine oxidase enzyme signiﬁcantly.[10]
[19][20] Hence, it can be concluded that the glycosida-
tion or an increase in the polarity of the ﬂavonoids
may lead to a decrease or loss in their xanthine oxi-
dase inhibitory activity. The same samples were also
tested for their antioxidant activities by DPPH method
(Table 3). Among the extracts, crude MeOH extract
and H2O subextract displayed activity with IC50 values
of 43.6 and 37.7 lg/ml. Regarding the isolates, only
phenolic compounds showed moderate DPPH free
radical scavenging activities with IC50 values ranging
from 3.6 to 26.8 lg/ml.
Table 2. 13C-NMR (CD3OD, 125 MHz) data of compounds 1
– 3. d in ppm.
Position 1a 2a 3a
Aglycone
1 98.7 97.0 97.7
3 153.4 152.2 152.6
4 112.0 112.7 112.7
5 36.6 34.6 35.2
6 33.8 31.3 32.1
7 28.3 27.7 28.1
8 44.2 43.4 43.8
9 43.8 45.7 45.2
10 66.3 66.4 66.4
11 169.5 168.9 169.2
COOMe 51.6 51.3 51.6
Glc
10 100.6 97.9 98.2
20 74.6 74.9 74.6
30 77.8 75.8 75.8
40 71.8 71.6 71.6
50 75.7 78.5 78.5
60 64.4 62.6 62.6
Acyl
10 0 128.8 135.8 136.2
20 0 114.7 130.8 131.2
30 0 148.0 129.4 128.9
40 0 151.6 131.5 130.1
50 0 112.5 129.4 128.9
60 0 122.8 130.0 131.2
a 115.8 118.6 120.0
b 146.8 146.3 145.0
CO 168.8 167.4 166.5
40 0-MeO 56.4 – –
a Assignments are based on COSY, HSQC and HMBC experiments.
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Experimental Section
General
TLC: Precoated SiO2 60F254 plates (Merck, Darmstadt,
Germany); visualized under UV light and by spraying
with 1% vanillin/H2SO4 soln., followed by heating at
105 °C for 2 – 3 min. Column chromatography (CC):
SiO2 60 (0.063 – 0.200 mm; Merck, Darmstadt), Polya-
mide (Sigma–Aldrich, St. Louis, MO, USA), and Sephadex
LH-20 gel (Sigma–Aldrich, St. Louis, MO, USA). Medium-
pressure liquid chromatography (MPLC): Sepacore
Flash Systems X10/X50 (B€uchi Labortechnik AG, Flawil,
Switzerland), Redi sep columns (LiChroprep C18, 130 and
43 g, SiO2 12 and 4 g; Teledyne Isco, Lincoln, Nebraska,
USA). Semiprep. HPLC: Waters 2487 (Waters, Milford,
Massachusetts, USA). The reversed-phase HPLC column
(C18, 5 lm, 250 9 4 mm i.d., Merck, Darmstadt, Ger-
many). Optical rotations: PerkinElmer 341 polarimeter
(PerkinElmer, Waltham, Massachusetts, USA). UV Spectra:
HP Agilent 8453 spectrophotometer (Agilent Techonolo-
gies, Santa Clara, CA, USA); kmax in nm. IR Spectra (KBr):
PerkinElmer 2000 FT-IR spectrometer (PerkinElmer, Wal-
tham, Massachusetts, USA); m in cm1. NMR Spectra:
Bruker Avance DRX 500 instrument (Billerica, MA, USA;
500 (1H) and 125 MHz (13C)) in CD3OD; d in ppm rel. to
Me4Si as internal standard, J in Hz. HR-ESI-MS: Q Exactive
Orbitrap (Thermo Fisher Scientiﬁc, Waltham, MA, USA) in
MeOH; positive-ion mode; in m/z.
Plant Material
The aerial parts of Asperula involucrata WAHLENB. (Rubi-
aceae) were collected from Kayısdagı, _Istanbul, in May
2015. The plant material was authenticated by Dr.
Hasan Kırmızıbekmez. A voucher specimen (YEF 15007)
has been deposited with the Herbarium of Faculty of
Pharmacy, Yeditepe University, _Istanbul.
Extraction and Isolation
The shade-dried and powdered aerial parts of A.
involucrata (100 g) were extracted with MeOH for 2 h
(1.1 l 9 2) at 45 °C. The combined MeOH extracts
were concentrated under vacuum to yield a crude
extract (27 g) which was suspended in H2O (40 ml)
and partitioned with CHCl3 (3 9 40 ml) to obtain H2O
(16.3 g) and CHCl3 (7.1 g) subextracts. The H2O subex-
tract was fractionated over Polyamide column (75 g,
3.3 9 62 cm) eluting with a gradient solvent system
H2O/MeOH (100:0 – 0:100) to give six main fractions,
Frs. A – F. Fr. B (282 mg) was subjected to C18-Med-
ium Pressure Liquid Chromatography (LiChroprep
C18-MPLC, 43 g) eluting with stepwise H2O/MeOH gra-
dient (95:5 ? 20:80) to give ferulic acid 4-O-b-gluco-
pyranoside (9, 2 mg). Fr. D (656 mg) was submitted to
C18-MPLC (130 g) eluting with H2O/MeOH gradient
(90:10 ? 0:100) to yield eight main fractions, Frs.
D1 – D8. Rechromatography of Fr. D2 (35 mg) by
Sephadex LH-20 CC (6 g, 1.3 9 26 cm) eluting with
MeOH gave apigenin 7-O-rutinoside (7, 3 mg). Fr. D4
(70 mg) was applied to Medium Pressure Liquid Chro-
matography (SiO2, 12 g) eluting with CHCl3/MeOH
gradient (95:5 ? 70:30) to obtain adoxoside (4, 3 mg).
Fr. D6 (50 mg) was chromatographed on SiO2 (7 g,
1.3 9 20 cm) column using the gradient mixture of
CHCl3/MeOH (100:0 ? 92:8) as mobile phase to afford
involucratoside A (1, 8 mg). Similarly, separation of Fr.
D8 (113 mg) by SiO2 column chromatography using
CH2Cl2/MeOH/H2O (100:0:0 ? 85:15:1) gradient
yielded involucratoside B (2, 6 mg) along with a frac-
tion (32 mg) containing impure 3. Puriﬁcation of this
fraction by SiO2-MPLC (4 g) using a gradient solvent
system of CHCl3/MeOH (100:0 ? 80:20) gave involu-
cratoside C (3, 3 mg). Fr. E (480 mg) was subjected to
C18-MPLC (43 g) eluting with stepwise H2O/MeOH gra-
dient (90:10 ? 30:70) to obtain chlorogenic acid (8,
20 mg). Fr. F (699 mg) was subjected to semi-prepera-
tive RP-HPLC (MeOH/H2O 35:65) to purify apigenin
7-O-b-glucopyranoside (5, 3 mg) and luteolin 7-O-b-
glucopyranoside (6, 2 mg).
Involucratoside A (= Methyl (1S,4aS,7S,7aS)-1,4a,
5,6,7,7a-Hexahydro-1-({6-O-[(2E)-3-(3-hydroxy-
4-methoxyphenyl)prop-2-enoyl]-b-D-glucopyranosyl}-
oxy)-7-(hydroxymethyl)cyclopenta[c]pyran-4-carboxy-
late; 1). Amorphous powder. ½a26D = 68 (c = 0.1,
MeOH). UV (MeOH): 221, 239, 297 (sh), 326. IR (KBr):
3402, 2952, 1701, 1632, 1512, 1440. 1H-NMR: (Table 1).
Table 3. In vitro xanthine oxidase (XO) inhibitory and antioxi-
dant activities of extract, subextracts and isolates (1 – 9) from
Asperula involucrata
Sample XO-Inhibitory
activity (IC50,
lg/ml  SD)
Antioxidant
activity
(IC50, lg/ml  SD)
MeOH extract 186.9  47.4 43.6  0.90
H2O subextract 137.3  32.7 37.7  0.13
CHCl3 subextract 356.5  37.1 NA
1 – 3, 5 NA NA
4 NA 26.8  2.19
6 NA 19.9  0.89
7 NA 10.4  0.10
8 NA 3.60  0.15
9 NA 20.4  0.52
Ascorbic acid 0.60  0.13
Allopurinol 7.5  0.1 lM
NA, not active.
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13C-NMR (Table 2). HR-ESI-MS (pos.): 589.1905
([M + Na]+, C27H34NaO13
+; calc. 589.1897).
Involucratoside B (= Methyl (1S,4aS,7S,7aS)-
1,4a,5,6,7,7a-Hexahydro-7-(hydroxymethyl)-1-({2-O-
[(2E)-3-phenylprop-2-enoyl]-b-D-glucopyranosyl}oxy)-
cyclopenta[c]pyran-4-carboxylate; 2). Amorphous
powder. ½a26D = 99 (c = 0.1, MeOH). UV (MeOH): 218,
223, 278. IR (KBr): 3524, 2921, 1705, 1637, 1450. 1H-
NMR: (Table 1). 13C-NMR (Table 2). HR-ESI-MS (pos.):
543.1857 ([M + Na]+, C26H32NaO11
+; calc. 543.1842).
Involucratoside C (= Methyl (1S,4aS,7S,7aS)-1,4a,
5,6,7,7a-Hexahydro-7-(hydroxymethyl)-1-({2-O-[(2E)-
3-phenylprop-2-enoyl]-b-D-glucopyranosyl}oxy)cyclo-
penta[c]pyran-4-carboxylate; 3). Amorphous powder.
½a26D = 47 (c = 0.1, MeOH). UV (MeOH): 218, 223, 275.
IR (KBr): 3432, 2917, 1733, 1708, 1632, 1437. 1H-NMR
(500 MHz, CD3OD) and
13C-NMR (125 MHz, CD3OD):
see Tables 1 and 2. HR-ESI-MS: 543.1848 ([M + Na]+,
C26H32NaO11
+; calc. 543.1842).
Xanthine Oxidase Inhibitory Assay
Xanthine oxidase isolated from bovine milk (lyophi-
lized powder) and xanthine powder were purchased
from Sigma–Aldrich. The production of uric acid by
xanthine oxidase was measured at 290 nm for 3 min
in 96-well plate, using the plate reader FluoSTAR
OPTIMA (BMG LABTECH) Fluorescence, in a total vol-
ume of 300 ll as described in the literature.[21] Stock
solutions were prepared as recommended: 50 mM
potassium buffer, pH 7.5, 0.15 mM xanthine solution,
pH 7.5 and XO enzyme 0.04 units/ml. The stock solu-
tions of the extracts (12 g/ml) were prepared in DMSO
solution. 140 ll of buffer solution and 100 ll of xan-
thine solution were added to the wells, to give a ﬁnal
concentration of 33 and 0.05 mM, resp. Extracts and
compounds were added in appropriate volumes so
that the ﬁnal concentration of DMSO in the assay did
not exceed 3.3% of the total volume. The reaction
was initiated by automatic addition of 50 ll of XO
solution to a ﬁnal concentration of 0.006 units/ml.
Each sample was tested in triplicate. Allopurinol, the
positive control, was tested in different concentrations,
started from 10 to 0.3125 lg/ml in microdilution, to
achieve the IC50 value. The IC50 values were calculated
by analyzing the inhibitory percentage values of each
concentration using GraphPad Prism 5.04 software
(GraphPad Software Inc.) with nonlinear regression.
Antioxidant Activity Assay
The antioxidant activity of the extracts and pure com-
pounds (isolates) were evaluated by using DPPH free
radical scavenging method as described previously.[22]
Microdilution series were made on a 96 well micro-
plate from the sample solutions (1 mg/ml, prepared
with HPLC grade MeOH) beginning from 100 ll, in
three parallel copies. To each well 100 ll of DPPH
(2,2-diphenyl-1-picrylhydrazyl, Sigma–Aldrich, Germany)
solution (100 lM, dissolved in HPLC grade MeOH) was
added, to gain 200 ll ﬁnal volume. After 30 min of
storing at r.t. in dark conditions, the absorbance was
measured at 550 nm with a BMG Labtech FluoStar
Optima plate reader. As positive control 0.1 mg/ml
ascorbic acid solution was used. The evaluation of
EC50 values were carried out with the help of Graph-
pad Prism 6.05.
Supplementary Material
Supporting information for this article is available on the
WWW under https://doi.org/10.1002/cbdv.201600288.
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